NCT06642610View on ClinicalTrials.gov

CGM Dynamic Index for Predicting Prediabetes in Cystic Fibrosis

NARecruitingINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

June 15, 2025

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2026

Conditions
PrediabetesCystic Fibrosis (CF)Cystic Fibrosis-related Diabetes
Interventions
DEVICE

CGM Dynamic Index (CDI)

Participants will undergo one-time oral glucose tolerance test (OGTT) and a one-time use of a CGM device, which will be worn for up to 10 days.

Trial Locations (1)

46202

RECRUITING

Indiana University Health, University Hospital, Indianapolis

All Listed Sponsors
lead

Indiana University

OTHER